BURIONI, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 981
NA - Nord America 620
AS - Asia 62
SA - Sud America 6
OC - Oceania 5
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.676
Nazione #
US - Stati Uniti d'America 615
SE - Svezia 612
IT - Italia 249
FI - Finlandia 41
CN - Cina 36
DE - Germania 23
IE - Irlanda 21
IN - India 10
RO - Romania 9
FR - Francia 8
GB - Regno Unito 6
RU - Federazione Russa 6
SA - Arabia Saudita 6
CA - Canada 5
AU - Australia 4
BR - Brasile 4
NL - Olanda 4
SG - Singapore 4
IR - Iran 3
EC - Ecuador 2
HK - Hong Kong 2
CH - Svizzera 1
EU - Europa 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
ZA - Sudafrica 1
Totale 1.676
Città #
Princeton 171
Lawrence 168
Milan 83
Ashburn 79
New York 45
Helsinki 41
Shanghai 32
Bologna 22
Dublin 21
Rome 16
Pune 10
Seattle 10
Marino 8
Washington 6
Borås 5
Jeddah 5
London 5
Los Angeles 4
Toronto 4
Turin 4
Xi'an 4
Ancona 3
Campagna 3
Catania 3
Ferrara 3
Frankfurt Am Main 3
Melbourne 3
Riccione 3
Sorocaba 3
Verona 3
Bari 2
Bergamo 2
Castrovillari 2
Cenaia 2
Gatchina 2
Genoa 2
Naaldwijk 2
Paderno Dugnano 2
Pratola Peligna 2
Quarto 2
Quito 2
Rockville 2
Seregno 2
Stimigliano 2
Torre Annunziata 2
Bisceglie 1
Bloemfontein 1
Brescia 1
Candia 1
Central 1
Chieti 1
Cornate d'Adda 1
Fasano 1
Florence 1
Hamilton 1
Hanover 1
Karachi 1
Krimpen Aan Den Ijssel 1
Kwai Chung 1
Legnano 1
Littleton 1
Macerata 1
Manassas 1
Mazzano Romano 1
Metairie 1
Mountain View 1
Napoli 1
Nardò 1
Nuoro 1
Omsk 1
Padova 1
Pinehaven 1
Redwood City 1
Rende 1
Rho 1
Riverside 1
Riyadh 1
Rotterdam 1
Rovellasca 1
San Mateo 1
Segrate 1
Sheffield 1
St Petersburg 1
Sydney 1
São Paulo 1
Tehran 1
Teramo 1
Terni 1
Trieste 1
Venice 1
Volgograd 1
Yazd 1
Totale 847
Nome #
Salute : Le frontiere della medicina : Volumi dedicati alla Salute a cura di Roberto Burioni 114
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 35
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 29
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 27
Virus, la grande sfida : dal coronavirus alla peste : come la scienza può salvare l'umanità / Roberto Burioni ; con la collaborazione di Pier Luigi Lopalco 25
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 23
A Biologically-validated HCV E1E2 Heterodimer Structural Model 23
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 21
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 21
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 20
"Freezing" parasites in pre-Himalayan region, Himachal Pradesh: Experience with mini-FLOTAC 20
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 19
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 19
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 18
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 18
Bacteriophages and Their Immunological Applications against Infectious Threats 18
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 18
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 18
66. Vaccini antivirali 17
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 17
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 17
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 17
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 16
Major sports events and the transmission of sars-cov-2: Analysis of seven case-studies in europe 16
SARS-CoV-2 before and after Omicron: two different viruses and two different diseases? 15
A vector for the expression of recombinant monoclonal Fab fragments in bacteria 15
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 15
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 15
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 15
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 15
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 15
Anti-idiotype monoclonal antibodies as mimotopes of the HIV gp120 antigen 15
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 15
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 14
ANTI-HIV-1 RESPONSE ELICITED IN RABBITS BY ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMICKING THE CD4-BINDING SITE ON GP120 14
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 13
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 13
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 13
36. Meccanismi difensivi dell'ospite alle infezioni virali 13
63. Vaccini Antivirali 13
Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine-origin influenza A (H1N1) virus (S-OIV) infections 13
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 13
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 13
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 13
A new subtraction technique for molecular cloning of rare antiviral antibody specificities from phage display libraries 12
Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections 12
HCV E2 core structures and mAbs: something is still missing 12
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 12
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 12
Role and potential therapeutic use of antibodies against herpetic infections 12
Phage display for the production of human monoclonal antibodies against human pathogens 12
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room 12
Structural basis for a human broadly neutralizing influenza A hemagglutinin stem-specific antibody including H17/18 subtypes 11
An improved phage display vector for antibody repertoire cloning by construction of combinatorial libraries 11
A novel expression vector for production of epitope-tagged recombinant Fab-fragment in bacteria 11
Capitolo 39 Meccanismi difensivi dell'ospite alle infezioni virali 11
Human monoclonal recombinant antibody against NS3 HCV protein and methods therefor 11
Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections 11
A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes 10
Intracellular expression of recombinant human immunoglobulin (IGGI) against NS3 inhibits helicase activity and HCV replication in cell culture 10
A recombinant human Fab inhibits activity of HCVNS3 and negative strand RNA synthesis 10
39 Meccanismi difensivi dell'ospite alle infezioni virali 10
A closer look at prion strains: Characterization and important implications 10
Anticorpo monoclonale diretto contro il virus JC 10
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 10
Direct sequencing of Scedosporium apiospermum DNA in the diagnosis of a case of keratitis 10
Has SARS-CoV-2 reached peak fitness? 10
Molecular study and epitope mapping of the human antibody response against HCV/E2 glycoprotein by generation of monoclonal recombinant Fabs. 10
Omeopatia : bugie, leggende e verità 10
Assessing the human immune response to SARS-CoV-2 variants 10
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 9
Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation 9
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies 9
Molecular Diagnosis of Scedosporium apiospermum Keratitis. 9
HUMAN MONOCLONAL ANTIBODIES TO HERPES SIMPLEX VIRUS AND METHODS THEREFOR 9
Human Monoclonal Antibody Fab Fragments directed against HCV E2 glycoprotein and endowed with neutralizing activity 9
Comparative Evaluation of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time Of Flight (MALDI-TOF) Mass Spectrometry Systems for Identification of Yeasts of Medical Importance 9
A NEW PLASMID CLONING VECTOR FOR DIRECT-DETECTION OF RECOMBINANT CLONES, BASED ON INACTIVATION OF A BACTERIAL ACID PHOSPHATASE-ENCODING GENE 9
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 9
Blocking immunodominant epitopes by competitive deselection. 9
Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia 9
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 9
La formidabile impresa. La medicina dopo la rivoluzione mRNA 8
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs 8
Definition of biological activity and quantitation of different families of human anti-HCV/E2 antibodies by generation of human recombinant anti-E2 monoclonal Fab by phage display combinatorial repertoire library 8
Characterization of four major human B-cell epitopes on the surface of HCV E2 glycoprotein by generation of human monoclonal Fab from phage display antibody librariesis 8
Dissection of the IgA1 local response by construction of isotype-specific combinatorial libraries displayed on the surface of phage from gastro-jejunal biopsies. 8
Cost-effectiveness of blood culture and a multiplex real-time PCR in hematological patients with suspected sepsis: an observational propensity score-matched study 8
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV) 8
Phage Display Technology 8
Method for the preparation of new oligoclonal antibodies 8
Monoclonal antibodies having homosubtype cross-neutralization properties against influenza A viruses subtype H1 8
Potential role of the detection of enterobacterial DNA in blood for the management of neonatal necrotizing enterocolitis 8
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections 8
Risks of "blind" automated identification systems in medical microbiology 8
Microbiological Diagnosis of Sepsis: The Confounding Effects of a “Gold Standard” 8
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 8
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab 8
Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction 8
Natalizumab-Associated Progressive Multifocal Leukoencephalopathy 8
Totale 1.400
Categoria #
all - tutte 28.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.310


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 14 0 0 0 0 0 5 0 0 0 0 1
2020/202113 4 0 0 3 3 1 1 0 0 1 0 0
2021/2022142 0 0 7 41 6 3 17 14 6 27 7 14
2022/20231.104 387 281 95 11 11 135 48 56 55 3 14 8
2023/2024429 24 38 79 62 29 100 11 43 4 38 1 0
Totale 1.820